Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 375 entries
View as:

Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis

Phase: N/A Priority: Normal
NCT ID: NCT04076696 Org: User:
Start: 08/26/20 End: 08/26/21 Due: 08/26/22

Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02334527 Org: User:
Start: 03/17/15 End: 09/28/17 Due: 09/28/18

Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya

Phase: N/A Priority: Normal
NCT ID: NCT06263582 Org: User:
Start: 05/29/24 End: 08/06/24 Due: 08/06/25

VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06878547 Org: User:
Start: 03/07/25 End: 02/24/28 Due: 02/24/29

mHealth Physical Activity Intervention for Survivors of Adolescent and Young Adult Cancers

Phase: N/A Priority: Normal
NCT ID: NCT03386383 Org: User:
Start: 02/28/18 End: 03/25/19 Due: 03/25/20

Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00225420 Org: User:
Start: 08/31/05 End: 08/31/12 Due: 08/31/13

GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses

Phase: N/A Priority: Normal
NCT ID: NCT03819569 Org: User:
Start: 10/30/18 End: 04/18/24 Due: 04/18/25

Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN

Phase: N/A Priority: Normal
NCT ID: NCT03529422 Org: User:
Start: 10/07/19 End: 05/06/26 Due: 05/06/27

Assessing the Feasibility of Screening and Treating Anxiety and Depression in the Bone Marrow Transplant Population

Phase: N/A Priority: Normal
NCT ID: NCT04025190 Org: User:
Start: 02/22/18 End: 08/28/18 Due: 08/28/19

Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02008058 Org: User:
Start: 01/23/14 End: 09/30/17 Due: 09/30/18

HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Malawi

Phase: N/A Priority: Normal
NCT ID: NCT03160209 Org: User:
Start: 07/26/17 End: 12/31/22 Due: 12/31/23

Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00454324 Org: User:
Start: 04/30/06 End: 12/31/14 Due: 12/31/15

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT03721068 Org: User:
Start: 02/19/19 End: 06/19/39 Due: 06/19/40

Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00405366 Org: User:
Start: 11/30/06 End: 07/31/15 Due: 07/31/16

Impact of Physical and Occupational Therapy in New BMT Patients

Phase: N/A Priority: Normal
NCT ID: NCT05978583 Org: User:
Start: 01/01/23 End: 10/31/25 Due: 10/31/26

Metformin for the Treatment of Endometrial Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT01685762 Org: User:
Start: 01/10/13 End: 12/01/15 Due: 12/01/16

Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab

Phase: N/A Priority: Normal
NCT ID: NCT01262820 Org: User:
Start: 12/31/10 End: 10/31/14 Due: 10/31/15

Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC

Phase: N/A Priority: Normal
NCT ID: NCT04564989 Org: User:
Start: 11/19/20 End: 11/30/33 Due: 11/30/34

Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00266097 Org: User:
Start: 08/31/04 End: 09/30/11 Due: 09/30/12

Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT00073970 Org: User:
Start: 04/30/03 End: 01/31/06 Due: 01/31/07

Correcting Public Misperceptions About Very Low Nicotine Content Cigarettes

Phase: N/A Priority: Normal
NCT ID: NCT04974489 Org: User:
Start: 07/01/21 End: 08/03/21 Due: 08/03/22

Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa

Phase: N/A Priority: Normal
NCT ID: NCT05413798 Org: User:
Start: 05/11/23 End: 08/31/26 Due: 08/31/27

Immuno-Oncology Database and Bioregistry

Phase: N/A Priority: Normal
NCT ID: NCT04656873 Org: User:
Start: 05/20/21 End: 04/30/31 Due: 04/30/32

Physical Activity Intervention for Older Patients During Chemotherapy for Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02191969 Org: User:
Start: 06/30/14 End: 09/18/19 Due: 09/18/20

Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation

Phase: N/A Priority: Normal
NCT ID: NCT02844400 Org: User:
Start: 11/30/16 End: 12/31/18 Due: 12/31/19